If you have nonalcoholic fatty liver disease (NAFLD) or mild kidney impairment, semaglutide may help improve these conditions through weight loss and glycemic control
Mexican firm Glicerinas Industriales, S.A de C.V., refused entry to FDA (via phone) for a planned inspection at their manufacturing site scheduled to occur in May 2022 and, as a result, received a warning letter that drugs manufactured at the facility were adulterated
Patients should contact their GP or prescribing clinician if they experience persistent heartburn that does not respond to initial management strategies, particularly if symptoms occur more than twice weekly or significantly impact quality of life and daily activities
James, S., Montgomery, P., & Williams, K